 "Research")
Intrexon Corporation, a leader in the engineering and industrialisation of biology to improve the quality of life and health of the planet, and Johnson Matthey, a global leader in science that enables cleaner air, improved health and more efficient use of natural resources, have entered into an exclusive collaboration focused on the development of microbial strains for fermentative production of peptide-based active pharmaceutical ingredients (APIs).
Peptide-based APIs are used as highly effective treatments in numerous therapeutic classes. However due to their structural complexity, peptides often are costly and difficult to produce, requiring specialised equipment and reagents and lengthy synthetic sequences with
